Common Stock, Shares Authorized of BIOREGENX, INC. from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Bioregenx, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2022 to Q3 2025.
  • Bioregenx, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2025 was 1.5B shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)

BIOREGENX, INC. Quarterly Common Stock, Shares Authorized (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 1.5B 0 0% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 1.5B 0 0% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 1.5B 0 0% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 1.5B 0 0% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 1.5B +1B +200% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.5B +1B +200% Jun 30, 2024 10-Q 2024-10-09
Q1 2024 1.5B +1B +200% Mar 31, 2024 10-Q/A 2024-10-09
Q4 2023 1.5B +1B +200% Dec 31, 2023 10-K/A 2025-04-16
Q3 2023 500M Sep 30, 2023 10-Q 2023-11-20
Q2 2023 500M Jun 30, 2023 10-Q 2023-08-15
Q1 2023 500M Mar 31, 2023 10-Q 2023-05-22
Q4 2022 500M Dec 31, 2022 10-K 2024-04-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.